Skip to main content
. 2018 Dec 7;10(12):497. doi: 10.3390/cancers10120497

Table 3.

SBRT doses used in the treatment of Oligometastatic disease.

Site of Metastases Dose (Gy) No. of Fractions
Peripheral lung metastasis not adjacent to chest wall 54–60 3
Peripheral lung metastases adjacent to chest wall 55 5
Central lung metastases 60 8
Adrenal metastases 36 3
Liver metastases 30–60 3–10
Lymph node 30 3
Spine metastases 24 or 27 2 or 3
Bone (non-spine) metastases 30–45 3